Involving minority and underrepresented women in clinical trials: The National Centers of Excellence in Women's Health

被引:102
作者
Killien, M
Bigby, JA
Champion, V
Fernandez-Repollet, E
Jackson, RD
Kagawa-Singer, M
Kidd, K
Naughton, MJ
Prout, M
机构
[1] Univ Washington, Sch Nursing, Dept Family & Child Nursing, Seattle, WA 98195 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA
[5] Univ Puerto Rico, Sch Med, Dept Pharmacol, San Juan, PR 00936 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA
[7] Ohio State Univ, Ctr Comprehens Canc, Clin Trials Off, Columbus, OH 43210 USA
[8] Univ Calif Los Angeles, Sch Publ Hlth & Asian Amer Studies, Dept Community Hlth Sci, Los Angeles, CA USA
[9] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[10] Wake Forest Univ, Publ Hlth Sci Sch Med, Winston Salem, NC 27109 USA
[11] Boston Univ, Sch Med, Boston, MA 02118 USA
[12] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA
来源
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE | 2000年 / 9卷 / 10期
关键词
D O I
10.1089/152460900445974
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Recent attention to reducing health disparities among population groups has focused on the need to include in clinical studies, especially clinical trials, participants who represent the diversity of the populations to which study results will be applied. While scientists generally applaud the goal of broadening the characteristics of participants in clinical trials, they are faced with multiple challenges as they seek to include historically underrepresented populations in their research. This article examines the historical and sociocultural context of participation by underrepresented groups, especially women and minorities, in clinical trials, identifies major barriers and challenges facing researchers, and suggests strategies for meeting these challenges. The article draws upon the experiences of the investigators affiliated with the National Centers of Excellence of Women's Health (CoEs).
引用
收藏
页码:1061 / 1070
页数:10
相关论文
共 38 条
[1]  
Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
[2]  
[Anonymous], 1981, Bad blood
[3]  
[Anonymous], 1997, KILLING BLACK BODY
[4]  
[Anonymous], 1997, Principles of community engagement
[5]  
BATEMAN M, 1993, P ANN M AM SOC CLIN, V12, pA472
[6]   Participation of African Americans in clinical research [J].
Bonner, GJ ;
Miles, TP .
NEUROEPIDEMIOLOGY, 1997, 16 (06) :281-284
[7]   The women's health trial feasibility study in minority populations: Design and baseline descriptions [J].
Bowen, D ;
Clifford, CK ;
Coates, R ;
Evans, M ;
Feng, ZD ;
Fouad, M ;
George, V ;
Gerace, T ;
Grizzle, JE ;
Hall, WD ;
Hearn, M ;
Henderson, M ;
Kestin, M ;
Kristal, A ;
Leary, ET ;
Lewis, CE ;
Oberman, A ;
Prentice, R ;
Raczynski, J ;
Toivola, B ;
Urban, N .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (06) :507-519
[8]  
BULLINER B, 1997, P ANN M AM SOC CLIN, V16, pA155
[9]  
*CDCP, 1999, 111 CDCP
[10]   THE PREVALENCE OF ILLICIT-DRUG OR ALCOHOL-USE DURING PREGNANCY AND DISCREPANCIES IN MANDATORY REPORTING IN PINELLAS COUNTY, FLORIDA [J].
CHASNOFF, IJ ;
LANDRESS, HJ ;
BARRETT, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (17) :1202-1206